Pathophysiology of ischemic acute renal failure

Contributions to Nephrology

Volumn 132, Issue , 2001, Pages 7-21

  Sheridan, Alice M ^b   Bonventre, Joseph V ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE;

ACUTE KIDNEY FAILURE; HEMODYNAMICS; HUMAN; ISCHEMIA; KIDNEY; KIDNEY PROXIMAL TUBULE; LEUKOCYTE; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW; VASCULARIZATION;

HEMODYNAMIC PROCESSES; HUMANS; ISCHEMIA; KIDNEY; KIDNEY FAILURE, ACUTE; KIDNEY TUBULES, PROXIMAL; LEUKOCYTES; MITOGEN-ACTIVATED PROTEIN KINASES;

EID: 0035532658     PISSN: 03025144     EISSN: None     Source Type: Book Series    
DOI: 10.1159/000060075     Document Type: Article

References (97)

1. Bonventre JV: Mechanisms of ischemic acute renal failure. Kidney Int 1993;43:1160-1178.
2. Zuk A, Bonventre JV, Brown D, Matlin KS: Polarity, integrin and extracellular matrix dynamics in the post-ischemic rat kidney. Am J Physiol 1998;275:C711-C731.
3. Alejandro V, Scandling JD Jr, Sibley RK, Dafoe D, Alfrey E, Deen W, Myers BD: Mechanisms of filtration failure during postischemic injury of the human kidney. A study of the reperfused renal allograft. J Clin Invest 1995;95:820-831.
4. +-ATPase during postischemic injury to the renal allograft. Kidney Int 1999;55:963-975.
5. Vetterlein F, Pethö A, Schmidt G: Distribution of capillary blood flow in rat kidney during postischemic renal failure. Am J Physiol 1986;251:H510-H519.
6. Bonventre JV: Ischemic acute renal failure; in Jamison JL (ed): Textbook of Molecular Medicine. Cambridge, Blackwell Science, 1996.
7. Conger J: Hemodynamic factors in acute renal failure. Adv Ren Replace Ther 1997;4:25-37.
8. Sanz MJ, Johnston B, Issekutz A, Kubes P: Endothelin causes P-selectin-dependent leukocyte rolling and adhesion within rat mesenteric microvessels. Am J Physiol 1999;277:H1823-H1830.
9. Kon V, Yoshioka T, Fogo A, Ichikawa I: Glomerular actions of endothelin in vivo. J Clin Invest 1989;83:1762-1767.
10. Chan L, Chittinandana A, Shapiro JI, Shanley PF, Schrier RW: Effect of an endothelin-receptor antagonist on ischemic acute renal failure. Am J Physiol 1994;266:F135-F138.
11. Gellai M, Jugus M, Fletcher T, Nambi P, Ohlstein EH, Elliott JD, Brooks DP: Nonpeptide endothelin receptor antagonists. V. Prevention and reversal of acute renal failure in the rat by SB 209670. J Pharmacol Exp Ther 1995;275:200-206.
12. Mino N, Kobayashi M, Nakajima A, Amano H, Shimamoto K, Ishikawa K, Watanabe K, Nishikibe M, Yano M, Ikemoto F: Protective effect of a selective endothelin receptor antagonist, BQ-123, in ischemic acute renal failure in rats. Eur J Pharmacol 1992;221:77-83.
13. Braun C, Vetter S, Conzelmann T, Schaub M, Kirchengast M, van der Woude FJ, Rohmeiss P: Improved recovery following posttransplant acute renal failure in rat renal isografts with an oral endothelin - A receptor antagonist. Exp Nephrol 2000;8:283-290.
14. Erley CM, Heyne N, Rossmeier S, Vogel T, Risler T, Osswald H: Adenosine and extracellular volume in radiocontrast media-induced nephropathy. Kidney Int Suppl 1998;67:S192-S194.
15. Smith JA, Whitaker EM, Bowmer CJ, Yates MS: Differential expression of renal adenosine A (1) receptors induced by acute renal failure. Biochem Pharmacol 2000;59:727-732.
16. Kolonko A, Wiecek A, Kokot F: The nonselective adenosine antagonist theophylline does prevent renal dysfunction induced by radiocontrast agents. J Nephrol 1998;11:151-156.
17. Pflueger A, Larson TS, Nath KA, King BF, Gross JM, Knox FG: Role of adenosine in contrast media-induced acute renal failure in diabetes mellitus. Mayo Clin Proc 2000;75:1275-1283.
18. Peters H, Border WA, Noble NA: From rats to man: A perspective on dietary L-arginine supplementation in human renal disease. Nephrol Dial Transplant 1999;14:1640-1650.
19. Kourembanas S, McQuillan LP, Leung GK, Faller DV: Nitric oxide regulates the expression of vasoconstrictors and growth factors by vascular endothelium under both normoxia and hypoxia. J Clin Invest 1993;92:99-104.
20. Richard V, Hogie M, Clozel M, Loffler BM, Thuillez C: In vivo evidence of an endothelin-induced vasopressor tone after inhibition of nitric oxide synthesis in rats. Circulation 1995;91:771-775.
21. Linas SL, Whittenburg D, Repine JE: Nitric oxide prevents neutrophil-mediated acute renal failure. Am J Physiol 1996;272:F48-F54.
22. Noiri E, Gailit J, Sheth D, Magazine H, Gurrath M, Muller G, Kesslet H, Goligorsky MS: Cyclic RGD peptides ameliorate ischemic acute renal failure in rats. Kidney Int 1994;46:1050-1058.
23. Koivisto A, Pittner J, Froelich M, Persson AEG: Oxygen-dependent inhibition of respiration in isolated renal tubules by nitric oxide. Kidney Int 1999;55:2368-2375.
24. Liang M, Knox FG: Nitric oxide enhances the paracellular permeability of opossum kidney cells. Kidney Int 1999;55:2215-2223.
25. Wangsiripaisan A, Gengaro PE, Nemenoff RA, Ling H, Edelstein CL, Schrier RW: Effect of nitric oxide donors on renal tubular epithelial cell-matrix adhesion. Kidney Int 1999;55:2281-2288.
26. Linas SL, Shanley PF, Whittenburg D, Berger E, Repine JE: Neutrophils accentuate ischemiareperfusion injury in isolated perfused rat kidneys. Am J Physiol 1988;255:F728-F735.
27. Willinger CC, Schramek H, Pfaller K, Pfaller W: Tissue distribution of neutrophils in postischemic acute renal failure. Virchows Arch B 1992;62:237-243.
28. Heinzelmann M, Mercer-Jones MA, Passmore JC: Neutrophils and renal failure. Am J Kidney Dis 1999;34:384-399.
29. Hellberg PO, Kallskog TO: Neutrophil-mediated post-ischemic tubular leakage in the rat kidney. Kidney Int 1989;36:1240-1247.
30. Klausner JM, Paterson IS, Goldman G, Kobzik L, Rodzen C, Lawrence R, Valeri CR, Shepro D, Hechtman HB: Postischemic renal injury is mediated by neutrophils and leukotrienes. Am J Physiol 1989;256:F794-F802.
31. De Greef KE, Ysebaert DK, Ghielli M, Vercauteren S, Nouwen EJ, Eyskens EJ, De Broe ME: Neutrophils and acute ischemia-reperfusion injury. J Nephrol 1998;11:110-122.
32. Takada M, Nadeau KC, Shaw GD, Tilney NL: Prevention of late renal changes after initial ischemia/ reperfusion injury by blocking early selectin binding. Transplantation 1997;64:1520-1525.
33. Rabb H, Daniels F, O'Donnell M, Haq M, Saba SR, Keane W, Tang WW: Pathophysiologic role of T lymphocytes in renal ischemia-reperfusion injury in mice. Am J Renal Physiol 2000;279:F525-F531.
34. Kelly KJ, Williams WW Jr, Colvin RB, Meehan SM, Springer TA, Gutiérrez-Ramos JC, Bonventre JV: Intercellular adhesion molecule-1 knockout mice are protected against renal ischemia (abstract). J Am Soc Nephrol 1994;5:900.
35. Kelly KJ, Williams WW, Colvin RB, Meehan SM, Springer TA, Gutierrez-Ramos JC, Bonventre JV: Intercellular adhesion molecule-1 deficient mice are protected against renal ischemia. J Clin Invest 1996;97:1056-1063.
36. Paller MS: Effect of neutrophil depletion on ischemic renal injury in the rat. J Lab Clin Med 1989; 113:379-386.
37. Molitoris BA, Marrs J: The role of cell adhesion molecules in ischemic acute renal failure. Am J Med 1999;106:583-592.
38. Kelly KJ, Williams WW, Colvin RB, Bonventre JV: Antibody to intercellular adhesion molecule-1 protects the kidney against ischemic injury. Proc Natl Acad Sci USA 1994;91:812-816.
39. Rahman A, Kefer J, Bando M, Niles WD, Malik AB: E-selectin expression in human endothelial cells by TNF-alpha-induced oxidant generation and NF-κB activation. Am J Physiol 1998;275: L533-L544.
40. Donnahoo KK, Meng X, Ayala A, Cain MP, Harken AH, Meldrum DR: Early kidney TNF-alpha expression mediates neutrophil infiltration and injury after renal ischemia-reperfusion. Am J Physiol 1999;277:R922-R929.
41. Donnahoo KK, Meldrum DR, Shenkar R, Chung CS, Abraham E, Harken AH: Early renal ischemia, with or without reperfusion, activates NFkappaB and increases TNF-alpha bioactivity in the kidney. J Urol 2000;163:1328-1332.
42. Ishibashi N, Weisbrot-Lefkowitz M, Reuhl K, Inouye M, Mirochnitchenko O: Modulation of chemokine expression during ischemia/reperfusion in transgenic mice overproducing human glutathione peroxidases. J Immunol 1999;163:5666-5677.
43. Safirstein R, Megysesi J, Saggi SJ, Price PM, Poon M, Rollins BJ, Taubman MB: Expression of cytokine-like genes JE and KC is increased during renal ischemia. Am J Physiol 1991;261:F1095-F1101.
44. Homeister JW, Satoh PS, Kilgore KS, Lucchesi BR: Soluble complement receptor type 1 prevents human complement-mediated damage of the rabbit isolated heart. J Immunol 1993;150:1055-64.
45. Zhou W, Farrar CA, Abe K, Pratt JR, Marsh JE, Wang Y, Stahl GL, Sacks SH: Predominant role for C5b-9 in renal ischemia/reperfusion injury. J Clin Invest 2000;105:1363-1371.
46. Thadhani R, Pascual M, Bonventre JV: Acute renal failure. New Engl J Med 1996;334:1448-1460.
47. Lieberthal W: Biology of acute renal failure: Therapeutic implications. Kidney 1997;52:1102-1115.
48. Ruegg CE, Mandel LJ: Bulk isolation of renal PCT and PST II. Differential responses to anoxia and hypoxia. Am J Physiol 1990;259:F176-F185.
49. Bagnasco S, Good D, Balaban R, Burg M: Lactate production in isolated segments of the rat nephron. Am J Physiol 1985;248:F522-F526.
50. Torikai S: A bioenergetic explanation for the selective vulnerability of renal medullary tubules to hypoxia. Clin Sci (Colch) 1988;75:323-330.
51. Bonventre JV, Sukhatme VP, Bamberger M, Ouellette AJ, Brown D: Localization of the protein product of the immediate early growth response gene, Egr-1, in the kidney after ischemia and reperfusion. Cell Regul 1991;2:251-260.
52. Safirstein RL, Bonventre JV: Molecular response to ischemic and nephrotoxic acute renal failure; in Schlöndorff D, Bonventre JV (eds): Molecular Nephrology. New York, Dekker, 1995, pp 839-854.
53. Fanning AS, Mitic LL, Anderson JM: Transmembrane proteins in the tight junction barrier. J Am Soc Nephrol 1999;10:1337-1345.
54. Claude P: Morphologic factors influencing transepithelial permeability: A model for resistance of the zonula occludens. J Membr Biol 1978;39:219-232.
55. Schwartz JH, Shih T, Menza SA, Lieberthal W: ATP depletion increases tyrosine phosphorylation of beta-catenin and plakoglobin in renal tubular cells. J Am Soc Nephrol 1999;10:2297-2305.
56. Goligorsky MS, Lieberthal W, Racusen L, Simon EE: Integrin receptors in renal tubular epithelium: New insights into pathophysiology of acute renal failure (editorial). Am J Physiol 1993;264:F1-F8.
57. Goligorsky MS, DiBona GF: Pathogenetic role of Arg-Gly-Asp recognizing integrins in acute renal failure. Proc Natl Acad Sci USA 1993;90:5700-5704.
58. Kroshin VM, Sheridan AM, Lieberthal W: Functional and cytoskeletal changes induced by sublethal injury in proximal tubular epithelial cells. Am J Physiol 1994;266:F21-F30.
59. Schumer M, Colombel MC, Sawczuk IS, Gobé G, Connor J, O'Toole KM, Olsson CA, Wise GJ, Buttyan R: Morphologic, biochemical, and molecular evidence of apoptosis during the reperfusion phase after brief periods of renal ischemia. Am J Pathol 1992;140:831-838.
60. Lieberthal W, Levine J: Mechanisms of apoptosis and its potential role in renal tubular epithelial injury. Am J Physiol 1996;271:F477-F488.
61. Lieberthal W, Menza SA, Levine JS: Graded ATP depletion can cause necrosis or apoptosis of cultured mouse proximal tubular cells. Am J Physiol 1998;274:F325-FF327.
62. Lieberthal W, Triaca V, Levine JS: Mechanisms of cell death induced by cisplatin in proximal tubular epithelial cells: Apoptosis versus necrosis. Am J Physiol 1996;270:F700-F708.
63. Beeri R, Symon Z, Brezis M, Ben-Sasson SA, Baehr PH, Zager RA: Rapid DNA fragmentaion from hypoxia along the thick ascending limb of rat kidneys. Kidney Int 1995;47:1806-1810.
64. Oberbauer R, Rohrmoser M, Regele H, Muhlbacher F, Mayer G: Apoptosis of tubular epithelial cells in donor kidney biopsies predicts early renal allograft function. J Am Soc Nephrol 1999;10:2006-2013.
65. Vasco KA, Dewall RA, Riley AM: Effect of allopurinol in renal ischemia. Surgery 1972;71:787-790.
66. Paller MS: Renal work, glutathione and susceptibility to free radical-mediated postischemic injury. Kidney Int 1988;33:843-849.
67. +-ATPase activity induced by free radicals and by ischemia of kidney. Am J Physiol 1988;254:C330-C337.
68. Malis CD, Weber PC, Leaf A, Bonventre JV: Incorporation of marine lipids into mitochondrial membranes increases suscepibility to damage by calcium and reactive oxygen species: Evidence for enhanced activation of phospholipase A2 in mitochondria enriched with n-3 fatty acids. Proc Natl Acad Sci USA 1990;87:8845-8849.
69. Chatterjee PK, Cuzzocrea S, Thiemermann C: Inhibitors of poly(ADP-ribose) synthetase protect rat proximal tubules against oxidant stress. Kidney Int 1999;56:973-984.
70. Berger NA: Poly(ADP-ribose) in the cellular response to DNA damage. Radiat Res 1985;101:4-15.
71. Heller B, Wang ZQ, Wagner EF, Radons J, Burkle A, Fehsel K, Burkart K, Kolb H: Inactivation of the poly(ADP-ribose) polymerase gene affects oxygen radical and nitric oxide toxicity in islet cells. J Biol Chem 1995;270:11176-11180.
72. Thiermermann C, Bowes J, Myint FP, Vane JR: Inhibition of the activity of poly(ADP-ribose) synthetase reduces ischemia-reperfusion injury in the heart and skeletal muscle. Proc Natl Acad Sci USA 1997;94:679-683.
73. 2 but not apoptosis. Gastroenterology 1995;109:472-482.
74. Chatterjee PK, Zacharowski K, Cuzzocrea S, Otto M, Thiemermann C: Inhibitors of poly(ADPribose) synthetase reduce renal ischemia-reperfusion injury in the anesthetized rat in vivo. Faseb J 2000;14:641-651.
75. Kleinman JG, Worcester EM, Beshensky AM, Sheridan AM, Bonventre JV, Brown D: Upregulation of osteopontin expression by ischemia in rat kidney. Ann NY Acad Sci 1995;760:321-323.
76. Noiri E, Dickman K, Miller F, Romanov G, Romanov VI, Shaw R, Chambers AF, Rittling SR, Denhardt DT, Goligorsky MS: Reduced tolerance to acute renal ischemia in mice with a targeted disruption of the osteopontin gene. Kidney Int 1999;56:74-82.
77. Persy VP, Verstrepen WA, Ysebaert DK, De Greef KE, De Broe ME: Differences in osteopontin up-regulation between proximal and distal tubules after renal ischemia/reperfusion. Kidney Int 1999;56:601-611.
78. Hwang S, Lopez C, Heck D, Gardner C, Laskin DL, Denhardt DT: Osteopontin inhibits induction of nitric oxide synthase activity by inflammatory mediators in mouse kidney epithelial cells. J Biol Chem 1994;269:711-715.
79. 2 enzymatic activity after renal ischemia and reperfusion. J Clin Invest 1991;87:1810-1818.
80. 2 activation in rabbit renal proximal tubules. Am J Physiol 1992;262:F354-F360.
81. Venkatachalam MA, Patel YJ, Kreisberg JI, Weinberg JM: Energy thresholds that determine membrane integrity and injury in a renal epithelial cell line (LLC-PK1). Relationships to phospholipid degradation and unesterified fatty acid accumulation. J Clin Invest 1988;81:745-758.
82. Sheridan AM, Schwartz JH, Kroshian VM, Tercyak AM, Laraia J, Masino S, Lieberthal W: Renal mouse proximal tubular cells are more susceptible than MDCK cells to chemical anoxia. Am J Physiol 1993;265:F342-F350.
83. Kelly KJ, Tolkoff-Rubin NE, Rubin RH, Williams WW, Meeham SM, Meschter CL, Christenson J, Bonventre JV: An oral platelet-activating factor antagonist, Ro 24-4736, protects the rat kidney from ischemic injury. Am J Physiol 1996;271:F1061-F1067.
84. Lopez-Novoa JM: Potential role of platelet activating factor in acute renal failure. Kidney Int 1999; 55:1672-1682.
85. 2-isoprostane formation in renal tubular cells and rat kidney. Kidney Int 1999;55:1759-1762.
86. 2-isoprostane stimulates cell proliferation and endothelin-1 expression on endothelial cells. Kidney Int 1999;56:471-478.
87. Dennis EA: The growing phospholipase A2 superfamily of signal transduction enzymes. Trends Biochem Sci 1997;22:1-2.
88. 4 pathway to inflammation control. Nature 1996;384:39-43.
89. Portilla D: Carnitine palmitoyltransferase enzyme inhibition protects proximal tubules during hypoxia. Kidney Int 1997;52:429-437.
90. 2 in ischemic acute renal failure. Curr Opin Nephrol Hypertens 1999;8:473-477.
91. Bonventre JV, Force T: Mitogen-activated protein kinases and transcriptional responses in renal injury and repair. Curr Opin Nephrol Hypertens 1998;7:425-433.
92. Force T, Alessandrini A, Bonventre JV: Cell signalling; in Seldin D, Giebisch G (eds): The Kidney: Physiology and Pathophysiology. New York, Lippincott-Raven, 2000.
93. Pombo CM, Bonventre JV, Avruch J, Woodgett JR, Kyriakis JM, Force T: The stress-activated protein kinases are major c-jun amino-terminal kinases activated by ischemia and reperfusion. J Biol Chem 1994;269:26545-26551.
94. Di Mari JF, Davis R, Safirstein RL: MAPK activation determines renal epithelial cell survival during oxidative injury. Am J Physiol 1999;277:F195-F203.
95. Ichimura T, Bonventre JV: Growth factors, signaling, and renal injury and repair; in Molitoris BA, Finn WF (eds): Acute Renal Failure. New York, Harcourt Health Sciences, 2000.
96. Nadasdy T, Laszik Z, Blick KE, Johnson DL, Burst-Singer K, Nast C, Cohen AH, Ormos J, Silva FG: Human acute tubular necrosis: A lectin and immunohistochemical study. Hum Pathol 1995; 26:230-239.
97. Witzgall R, Brown D, Schwarz C, Bonventre JV: Localization of proliferating cell nuclear antigen, vimentin, c-fos, and clusterin in the post-ischemic kidney. Evidence for a heterogeneous genetic response among nephron segments, and a large pool of mitotically active and dedifferentiated cells. J Clin Invest 1994;93:2175-2188.